Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic CardiomyopathyJonathan P. Law, Charles J. Ferro, Chris J. Weston et al.|Journal of the American Heart Association|2020Cited by 32